首页 > 最新文献

Neurourology and Urodynamics最新文献

英文 中文
Urodynamics in Focus: Applications, Controversies, and Evolving Practices. 泌尿动力学的焦点:应用,争议和不断发展的实践。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-03 DOI: 10.1002/nau.70203
Joshua A Cohn, Brian J Linder
{"title":"Urodynamics in Focus: Applications, Controversies, and Evolving Practices.","authors":"Joshua A Cohn, Brian J Linder","doi":"10.1002/nau.70203","DOIUrl":"10.1002/nau.70203","url":null,"abstract":"","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"253"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Urodynamics in Assessing Lower Urinary Tract Symptoms Post-Radical Prostatectomy: A Review. 尿动力学在评估根治性前列腺切除术后下尿路症状中的作用:综述。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-10-09 DOI: 10.1002/nau.70157
Dora Jericevic Schwartz, Suditi Rahematpura, Benjamin Brucker

Introduction: This review examines the role of urodynamics (UDS) in evaluating lower urinary tract symptoms (LUTS) following radical prostatectomy. We first present typical urodynamic findings in post-prostatectomy men, then discuss applications of UDS, and finally examine treatment pathways for post-prostatectomy LUTS beyond stress urinary incontinence (SUI) surgery.

Methods: A narrative review was performed focusing on the current primary literature and society guidelines on the role of UDS post-prostatectomy.

Results: LUTS after prostatectomy are common, most frequently storage LUTS, specifically SUI. For the index patient with clinically suspected SUI after prostate treatment, routine UDS before SUI surgery have not been shown to impact postsurgical continence outcomes. In cases where there is diagnostic uncertainty following noninvasive lower urinary tract evaluation, UDS plays an important role. UDS are highly beneficial in complex scenarios, such as severe mixed LUTS, prior radiation therapy, impaired bladder compliance, detrusor underactivity, and/or previous SUI surgery. Fluoroscopy during UDS and cystoscopy can provide additional clarity and confirmation of the diagnosis suggested by UDS.

Conclusion: UDS are useful adjuncts in appropriately selected post-prostatectomy patients with LUTS, typically with complicating factors.

简介:本综述探讨了尿动力学(UDS)在评估根治性前列腺切除术后下尿路症状(LUTS)中的作用。我们首先介绍前列腺切除术后男性的典型尿动力学结果,然后讨论UDS的应用,最后探讨前列腺切除术后LUTS在压力性尿失禁(SUI)手术之外的治疗途径。方法:对目前主要文献和社会指南中关于UDS在前列腺切除术后的作用进行综述。结果:前列腺切除术后的LUTS是常见的,最常见的是存储LUTS,特别是SUI。对于前列腺治疗后临床怀疑SUI的指数患者,SUI术前常规UDS未显示对术后尿失禁结果的影响。在无创下尿路评估后诊断不确定的情况下,UDS发挥了重要作用。UDS在复杂情况下非常有用,如严重的混合性LUTS、既往放射治疗、膀胱顺应性受损、逼尿肌活动不足和/或既往SUI手术。超声造影和膀胱镜检查可进一步明确和确认超声造影建议的诊断。结论:UDS是适当选择的前列腺切除术后LUTS患者的有效辅助手段,通常伴有并发症。
{"title":"The Role of Urodynamics in Assessing Lower Urinary Tract Symptoms Post-Radical Prostatectomy: A Review.","authors":"Dora Jericevic Schwartz, Suditi Rahematpura, Benjamin Brucker","doi":"10.1002/nau.70157","DOIUrl":"10.1002/nau.70157","url":null,"abstract":"<p><strong>Introduction: </strong>This review examines the role of urodynamics (UDS) in evaluating lower urinary tract symptoms (LUTS) following radical prostatectomy. We first present typical urodynamic findings in post-prostatectomy men, then discuss applications of UDS, and finally examine treatment pathways for post-prostatectomy LUTS beyond stress urinary incontinence (SUI) surgery.</p><p><strong>Methods: </strong>A narrative review was performed focusing on the current primary literature and society guidelines on the role of UDS post-prostatectomy.</p><p><strong>Results: </strong>LUTS after prostatectomy are common, most frequently storage LUTS, specifically SUI. For the index patient with clinically suspected SUI after prostate treatment, routine UDS before SUI surgery have not been shown to impact postsurgical continence outcomes. In cases where there is diagnostic uncertainty following noninvasive lower urinary tract evaluation, UDS plays an important role. UDS are highly beneficial in complex scenarios, such as severe mixed LUTS, prior radiation therapy, impaired bladder compliance, detrusor underactivity, and/or previous SUI surgery. Fluoroscopy during UDS and cystoscopy can provide additional clarity and confirmation of the diagnosis suggested by UDS.</p><p><strong>Conclusion: </strong>UDS are useful adjuncts in appropriately selected post-prostatectomy patients with LUTS, typically with complicating factors.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"270-278"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145258592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Effectiveness of Botulinum Toxin a Versus Placebo for Neurogenic Overactive Bladder: A Meta-Analysis. a型肉毒毒素与安慰剂治疗神经源性膀胱过动症的疗效比较:荟萃分析。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2026-01-14 DOI: 10.1002/nau.70211
Konstantinos Tassoudis, Zachos Ioannis, Dimitropoulos Konstatninos, Evmorfopoulos Konstantinos, Marsitopoulos Konstantinos, Vassilios Tassoudis, Vassilios Tzortzis
<p><strong>Background: </strong>Lower urinary tract (LUT) dysfunctions affect millions of patients globally. LUT dysfunctions are extremely common in patients with neurological diseases. Worldwide, subtype A of Botulinum Toxin A (BTXA) is regularly used to treat these disorders.</p><p><strong>Introduction: </strong>LUT dysfunctions have various patterns of expression. The most prevalent of these is neurogenic detrusor overactivity (NDO), which is strongly associated with neurological diseases and can significantly impact a patient's life.</p><p><strong>Objective: </strong>Onabotulinumtoxin A is a widely used drug for the treatment of neurogenic bladder. The purpose of this study is to evaluate its efficacy and safety across different dosages in patients with the condition.</p><p><strong>Data sources: </strong>Pubmed, Scopus, Web of Science.</p><p><strong>Review methods: </strong>Systematic literature review was performed to identify randomized, double-blind, placebo-controlled trials of onabotulinumtoxin A for NDO. Seven randomized controlled trials were incorporated in this meta-analysis. The primary outcome concerned urodynamic parameters, including Maximum Cystometric Capacity (MCC) and Maximum Detrusor Pressure (MDP); the mean number of Urinary Incontinence (UI) episodes per week was also assessed. Safety was evaluated by the incidence of various Adverse Events (AE). Data was extracted by two authors and statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS v.29).</p><p><strong>Results: </strong>Seven RCTs involving 1592 patients in total were included in the study, following screening of 1602 potentially relevant articles. The Onabotulinumtoxin A-treated groups showed a significant increase in MCC (Mean Difference ([MD]: 128.866, 95% Confidence Interval [CI]: 98.836, 158.896, p < 0.001, in the group that received 200 Units of Onabotulinumtoxin A; MD: 151.389, CI: 106.006, 196.773, p < 0.005, in the group that received 300Units of Onabotulinumtoxin A). There was also a significant decrease in MDP in the Onabotulinumtoxin A-treated groups (MD: -29.051, CI: -39.557, -18.545, p < 0.002, 200 U group; MD: -31.751, CI: -45.226, -18.276, p < 0.01, 300 U group). Additionally, no effect was noticed in the mean number of UI episodes per week (MD: -10.69, 95% CI: -33.86, 12.49, p = 0.11; MD: -10.55, 95% CI: -59.06, 37.97, p = 0.22, 200 U and 300 U respectively). Taking AEs into consideration, Onabotulinumtoxin A-treated groups were often associated with more complications, including urinary tract infections (UTI) (LogOR: 0.341, CI: 0.011, 0.67, p = 0.045, 200 U group; LogOR: 0.424, CI: 0.075, 0.773, p = 0.028, 300 U group) and urinary retention (UR) (LogOR: 1.746, CI: 0.869, 2.623, p = 0.008, 200 U group; LogOR: 1.879, CI: 0.679, 3.078, p = 0.021, 300 U group).</p><p><strong>Conclusions: </strong>Our meta-analyses found that Onabotulinumtoxin A can be beneficial in improving the urodynamic parameters (MCC and M
背景:下尿路(LUT)功能障碍影响着全球数百万患者。LUT功能障碍在神经系统疾病患者中极为常见。在世界范围内,A型肉毒毒素A (BTXA)经常用于治疗这些疾病。LUT功能障碍具有多种表达模式。其中最常见的是神经源性逼尿肌过度活动(NDO),这与神经系统疾病密切相关,并可能严重影响患者的生活。目的:肉毒杆菌毒素A是一种广泛应用于治疗神经源性膀胱的药物。本研究的目的是评估其在不同剂量下对患者的疗效和安全性。数据来源:Pubmed, Scopus, Web of Science。综述方法:采用系统的文献综述来确定肉毒杆菌毒素A治疗NDO的随机、双盲、安慰剂对照试验。本荟萃分析纳入了7项随机对照试验。主要结局涉及尿动力学参数,包括最大膀胱容量(MCC)和最大逼尿肌压力(MDP);每周尿失禁(UI)发作的平均次数也被评估。通过各种不良事件(AE)的发生率来评估安全性。数据由两位作者提取,并使用社会科学统计软件包(SPSS v.29)进行统计分析。结果:在筛选了1602篇可能相关的文章后,共纳入了7项随机对照试验,共涉及1592例患者。单肉毒杆菌毒素a治疗组MCC显著升高(平均差值[MD]: 128.866, 95%可信区间[CI]: 98.836, 158.896, p)。结论:我们的荟萃分析发现单肉毒杆菌毒素a可改善尿动力学参数(MCC和MDP)。就安全性而言,药物治疗组发生尿路感染或尿路感染的可能性略高。
{"title":"Comparative Effectiveness of Botulinum Toxin a Versus Placebo for Neurogenic Overactive Bladder: A Meta-Analysis.","authors":"Konstantinos Tassoudis, Zachos Ioannis, Dimitropoulos Konstatninos, Evmorfopoulos Konstantinos, Marsitopoulos Konstantinos, Vassilios Tassoudis, Vassilios Tzortzis","doi":"10.1002/nau.70211","DOIUrl":"10.1002/nau.70211","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Lower urinary tract (LUT) dysfunctions affect millions of patients globally. LUT dysfunctions are extremely common in patients with neurological diseases. Worldwide, subtype A of Botulinum Toxin A (BTXA) is regularly used to treat these disorders.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;LUT dysfunctions have various patterns of expression. The most prevalent of these is neurogenic detrusor overactivity (NDO), which is strongly associated with neurological diseases and can significantly impact a patient's life.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Onabotulinumtoxin A is a widely used drug for the treatment of neurogenic bladder. The purpose of this study is to evaluate its efficacy and safety across different dosages in patients with the condition.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data sources: &lt;/strong&gt;Pubmed, Scopus, Web of Science.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Review methods: &lt;/strong&gt;Systematic literature review was performed to identify randomized, double-blind, placebo-controlled trials of onabotulinumtoxin A for NDO. Seven randomized controlled trials were incorporated in this meta-analysis. The primary outcome concerned urodynamic parameters, including Maximum Cystometric Capacity (MCC) and Maximum Detrusor Pressure (MDP); the mean number of Urinary Incontinence (UI) episodes per week was also assessed. Safety was evaluated by the incidence of various Adverse Events (AE). Data was extracted by two authors and statistical analysis was carried out using the Statistical Package for the Social Sciences (SPSS v.29).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Seven RCTs involving 1592 patients in total were included in the study, following screening of 1602 potentially relevant articles. The Onabotulinumtoxin A-treated groups showed a significant increase in MCC (Mean Difference ([MD]: 128.866, 95% Confidence Interval [CI]: 98.836, 158.896, p &lt; 0.001, in the group that received 200 Units of Onabotulinumtoxin A; MD: 151.389, CI: 106.006, 196.773, p &lt; 0.005, in the group that received 300Units of Onabotulinumtoxin A). There was also a significant decrease in MDP in the Onabotulinumtoxin A-treated groups (MD: -29.051, CI: -39.557, -18.545, p &lt; 0.002, 200 U group; MD: -31.751, CI: -45.226, -18.276, p &lt; 0.01, 300 U group). Additionally, no effect was noticed in the mean number of UI episodes per week (MD: -10.69, 95% CI: -33.86, 12.49, p = 0.11; MD: -10.55, 95% CI: -59.06, 37.97, p = 0.22, 200 U and 300 U respectively). Taking AEs into consideration, Onabotulinumtoxin A-treated groups were often associated with more complications, including urinary tract infections (UTI) (LogOR: 0.341, CI: 0.011, 0.67, p = 0.045, 200 U group; LogOR: 0.424, CI: 0.075, 0.773, p = 0.028, 300 U group) and urinary retention (UR) (LogOR: 1.746, CI: 0.869, 2.623, p = 0.008, 200 U group; LogOR: 1.879, CI: 0.679, 3.078, p = 0.021, 300 U group).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Our meta-analyses found that Onabotulinumtoxin A can be beneficial in improving the urodynamic parameters (MCC and M","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"335-352"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145966316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal Duration of Hydrodistension for Symptomatic Treatment of Interstitial Cystitis: A Systematic Review. 对症治疗间质性膀胱炎的最佳腹水扩张时间:系统回顾。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-29 DOI: 10.1002/nau.70190
Sean Lim, Zein Alhamdani, Kirby R Qin, Alexander Nesbitt, Paul Manohar, Matthew Harper, Scott Donnellan, Janelle Brennan, Weranja Ranasinghe
<p><strong>Introduction: </strong>Interstitial cystitis (IC) is a chronic pelvic condition in the absence of other pathology leading to significant morbidity with limited available treatment options. Cystoscopic hydrodistension (HD) remains an offered intervention for diagnosis and management, providing temporary relief in some patients. There is no overall consensus regarding the optimal duration of HD. This systematic review aims to comprehensively assess the existing literature to identify if there is a relationship between HD time and treatment efficacy.</p><p><strong>Materials and methods: </strong>A systematic search in MEDLINE, Embase, and PubMed between January 1969 to April 2024 was performed to identify relevant articles investigating the efficacy of HD as a sole treatment for IC. Two independent reviewers screened abstracts and full texts, and a third resolved conflicts. Quality assessment was performed by two independent blinded authors using The Risk Of Bias In Non-randomized Studies - of Interventions (ROBINS-I) assessment tool. Data regarding population characteristics, duration of HD, treatment number and method, outcome measurements and values were extracted. Included articles were subcategorized into standard (< 15 min) and prolonged (> 15 min) HD durations.</p><p><strong>Results: </strong>A total of 1404 patients in 14 studies were included. Ten studies were prospective or retrospective cohort studies, and four were randomized controlled trials. Nine trials investigated the effect of HD for 15 min or less. Of these, four demonstrated no statistically significant differences in preoperative and post operative symptoms and voiding function between 1 month and 6 months. Four trials found significant improvement in subjective patient symptom scores. Of these, one study investigated two groups of different HD times via different surgeons, and found significant improvements in pain scores for patients in those undergoing HD for 2 min (Pre: 2.4 vs. Post: 5.5) and over 5 min (Pre: 1.3 vs. Post: 3.6). A final study found a time to therapeutic failure post 3 min HD of 25.2 months. Five trials performed prolonged HD between 30 min to 2 h in a total of 152 patients. All were older studies (1977-2003) and performed HD under spinal or local anesthetic. These studies demonstrated long term symptomatic improvement in included participants (32.3%-67.3%) with follow up durations of 7 months to 3.2 years. Overall risk of bias across domains was assessed as high between included studies.</p><p><strong>Conclusions: </strong>HD remains a contentious treatment option for IC, with limited long-term results in the literature. Our study suggests longer HD times may result in improved efficacy and duration of symptom relief but in the setting of potentially increased risks of severe complications including bladder perforation. Risk of bias, observational study designs, heterogeneity, and lack direct comparisons in durations of HD limits our conclusions.
简介:间质性膀胱炎(IC)是一种慢性盆腔疾病,在没有其他病理的情况下导致显著的发病率和有限的可用治疗方案。膀胱镜下腹水膨胀(HD)仍然是一种诊断和治疗的干预措施,对一些患者提供了暂时的缓解。关于HD的最佳持续时间没有全面的共识。本系统综述旨在全面评估现有文献,以确定HD时间与治疗效果之间是否存在关系。材料和方法:对MEDLINE、Embase和PubMed 1969年1月至2024年4月进行系统检索,以确定研究HD作为IC唯一治疗方法有效性的相关文章。两位独立审稿人筛选摘要和全文,第三位审稿人解决冲突。质量评估由两位独立的盲法作者使用非随机干预研究的偏倚风险(ROBINS-I)评估工具进行。提取有关人群特征、HD持续时间、治疗次数和方法、结果测量值和值的数据。纳入的文章被细分为标准(15分钟)高清时长。结果:14项研究共纳入1404例患者。10项研究为前瞻性或回顾性队列研究,4项为随机对照试验。9项试验调查了HD治疗15分钟或更短时间的效果。其中4例患者1个月和6个月的术前、术后症状和排尿功能无统计学差异。四项试验发现患者主观症状评分显著改善。其中,一项研究通过不同的外科医生调查了两组不同的HD时间,发现接受HD 2分钟(术前:2.4 vs后:5.5)和超过5分钟(术前:1.3 vs后:3.6)的患者疼痛评分有显著改善。最后一项研究发现,3分钟HD后治疗失败的时间为25.2个月。五项试验在152例患者中进行了30分钟至2小时的延长HD。所有研究均为较早的研究(1977-2003),在脊髓或局部麻醉下进行HD。这些研究表明纳入的参与者(32.3%-67.3%)的长期症状改善,随访时间为7个月至3.2年。在纳入的研究中,跨领域的总体偏倚风险被评估为高。结论:HD仍然是IC的一种有争议的治疗选择,文献中长期效果有限。我们的研究表明,更长的HD时间可能会改善疗效和症状缓解的持续时间,但可能会增加严重并发症(包括膀胱穿孔)的风险。偏倚风险、观察性研究设计、异质性以及缺乏HD持续时间的直接比较限制了我们的结论。这篇综述强调需要更大规模的前瞻性试验来确定HD持续时间对治疗效果的影响。
{"title":"Optimal Duration of Hydrodistension for Symptomatic Treatment of Interstitial Cystitis: A Systematic Review.","authors":"Sean Lim, Zein Alhamdani, Kirby R Qin, Alexander Nesbitt, Paul Manohar, Matthew Harper, Scott Donnellan, Janelle Brennan, Weranja Ranasinghe","doi":"10.1002/nau.70190","DOIUrl":"10.1002/nau.70190","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Interstitial cystitis (IC) is a chronic pelvic condition in the absence of other pathology leading to significant morbidity with limited available treatment options. Cystoscopic hydrodistension (HD) remains an offered intervention for diagnosis and management, providing temporary relief in some patients. There is no overall consensus regarding the optimal duration of HD. This systematic review aims to comprehensively assess the existing literature to identify if there is a relationship between HD time and treatment efficacy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Materials and methods: &lt;/strong&gt;A systematic search in MEDLINE, Embase, and PubMed between January 1969 to April 2024 was performed to identify relevant articles investigating the efficacy of HD as a sole treatment for IC. Two independent reviewers screened abstracts and full texts, and a third resolved conflicts. Quality assessment was performed by two independent blinded authors using The Risk Of Bias In Non-randomized Studies - of Interventions (ROBINS-I) assessment tool. Data regarding population characteristics, duration of HD, treatment number and method, outcome measurements and values were extracted. Included articles were subcategorized into standard (&lt; 15 min) and prolonged (&gt; 15 min) HD durations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 1404 patients in 14 studies were included. Ten studies were prospective or retrospective cohort studies, and four were randomized controlled trials. Nine trials investigated the effect of HD for 15 min or less. Of these, four demonstrated no statistically significant differences in preoperative and post operative symptoms and voiding function between 1 month and 6 months. Four trials found significant improvement in subjective patient symptom scores. Of these, one study investigated two groups of different HD times via different surgeons, and found significant improvements in pain scores for patients in those undergoing HD for 2 min (Pre: 2.4 vs. Post: 5.5) and over 5 min (Pre: 1.3 vs. Post: 3.6). A final study found a time to therapeutic failure post 3 min HD of 25.2 months. Five trials performed prolonged HD between 30 min to 2 h in a total of 152 patients. All were older studies (1977-2003) and performed HD under spinal or local anesthetic. These studies demonstrated long term symptomatic improvement in included participants (32.3%-67.3%) with follow up durations of 7 months to 3.2 years. Overall risk of bias across domains was assessed as high between included studies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;HD remains a contentious treatment option for IC, with limited long-term results in the literature. Our study suggests longer HD times may result in improved efficacy and duration of symptom relief but in the setting of potentially increased risks of severe complications including bladder perforation. Risk of bias, observational study designs, heterogeneity, and lack direct comparisons in durations of HD limits our conclusions. ","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"324-334"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145636739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjustable TransObturator Male System (ATOMS) After Desobstructive Surgery for Benign Prostatic Hyperplasia - Does the Type of Desobstructive Surgery Make a Difference? 良性前列腺增生去梗阻手术后可调节的男性transboturator系统(ATOMS) -去梗阻手术的类型有区别吗?
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2026-01-18 DOI: 10.1002/nau.70213
Leo Federico Stadelmeier, Elisa Lederer, Ferdinand Heimke, Marc Kidess, Nikolaos Pyrgidis, Troya Georgieva, Julian Hermans, Marina Hoffmann, Benedikt Ebner, Alexander Tamalunas, Patrick Keller, Michael Chaloupka, Ricarda Bauer, Julian Marcon, Philipp Weinhold, Christian G Stief, Yannic Volz

Objective: To assess the surgical safety, efficacy and quality of life in patients suffering from stress urinary incontinence after desobstructive surgery for benign prostatic enlargement, we analyzed data from patients treated with the Adjustable Transobturator Male System (ATOMS) at our tertiary referral center.

Methods: We retrospectively analyzed 27 patients with stress urinary incontinence (SUI) after desobstructive surgery (transurethral resection of the prostate (TUR-P): n = 17; Holmium laser enucleation of the prostate (HoLEP): n = 10) who underwent ATOMS implantation at our high-volume incontinence-surgery center between 2018 and 2024. Patients with prior prostatectomy or cancer-related surgery were excluded. Pre- and postoperative continence parameters, complications, and patient-reported outcomes were assessed using questionnaires, 24-h pad tests, and standardized instruments. The median follow-up was 32 months.

Results: Baseline demographics were comparable across groups. HoLEP patients had a significantly higher resected tissue weight (95.0 g vs. 26.0 g, p = 0.008) and required greater cushion volume (8.0 ml vs. 7.0 ml, p = 0.035). Complete continence rates were 64.7% (TUR-P) and 80.0% (HoLEP, p = 0.401). Postoperative pad test results (12.0 ml vs. 11.0 ml), complication rates, and satisfaction levels showed no significant differences. Explantation occurred in ~10% of patients, with high patient-reported satisfaction and willingness to recommend the implant across both groups.

Conclusion: ATOMS implantation is a feasible, safe, and effective treatment for SUI following both TUR-P and HoLEP. Importantly, neither the type of prior surgery nor the volume of resected prostate tissue negatively impacted outcomes. These findings support the broader application of ATOMS in patients with post-BPE SUI, including those with large prostate volumes.

目的:为了评估良性前列腺肿大去梗阻手术后压力性尿失禁患者的手术安全性、有效性和生活质量,我们分析了我们三级转诊中心使用可调男性transboturator System (ATOMS)治疗的患者的数据。方法:回顾性分析27例经尿道前列腺切除术(turp)后压力性尿失禁(SUI)患者:n = 17;钬激光前列腺去核术(HoLEP): n = 10例,于2018年至2024年间在我们的大容量失禁手术中心接受了ATOMS植入。既往有前列腺切除术或癌症相关手术的患者被排除在外。通过问卷调查、24小时尿垫试验和标准化仪器评估术前和术后尿失禁参数、并发症和患者报告的结果。中位随访时间为32个月。结果:各组间基线人口统计数据具有可比性。HoLEP患者的切除组织重量明显更高(95.0 g vs. 26.0 g, p = 0.008),需要更大的缓冲体积(8.0 ml vs. 7.0 ml, p = 0.035)。完全失禁率分别为64.7% (turp)和80.0% (HoLEP, p = 0.401)。术后尿垫试验结果(12.0 ml vs. 11.0 ml)、并发症发生率和满意度无显著差异。约10%的患者植入术成功,两组患者报告的满意度和推荐植入术的意愿都很高。结论:原子植入术是治疗turp和HoLEP合并SUI的一种可行、安全、有效的方法。重要的是,术前手术的类型和切除前列腺组织的体积都不会对结果产生负面影响。这些发现支持ATOMS在bpe后SUI患者中的更广泛应用,包括前列腺体积较大的患者。
{"title":"Adjustable TransObturator Male System (ATOMS) After Desobstructive Surgery for Benign Prostatic Hyperplasia - Does the Type of Desobstructive Surgery Make a Difference?","authors":"Leo Federico Stadelmeier, Elisa Lederer, Ferdinand Heimke, Marc Kidess, Nikolaos Pyrgidis, Troya Georgieva, Julian Hermans, Marina Hoffmann, Benedikt Ebner, Alexander Tamalunas, Patrick Keller, Michael Chaloupka, Ricarda Bauer, Julian Marcon, Philipp Weinhold, Christian G Stief, Yannic Volz","doi":"10.1002/nau.70213","DOIUrl":"10.1002/nau.70213","url":null,"abstract":"<p><strong>Objective: </strong>To assess the surgical safety, efficacy and quality of life in patients suffering from stress urinary incontinence after desobstructive surgery for benign prostatic enlargement, we analyzed data from patients treated with the Adjustable Transobturator Male System (ATOMS) at our tertiary referral center.</p><p><strong>Methods: </strong>We retrospectively analyzed 27 patients with stress urinary incontinence (SUI) after desobstructive surgery (transurethral resection of the prostate (TUR-P): n = 17; Holmium laser enucleation of the prostate (HoLEP): n = 10) who underwent ATOMS implantation at our high-volume incontinence-surgery center between 2018 and 2024. Patients with prior prostatectomy or cancer-related surgery were excluded. Pre- and postoperative continence parameters, complications, and patient-reported outcomes were assessed using questionnaires, 24-h pad tests, and standardized instruments. The median follow-up was 32 months.</p><p><strong>Results: </strong>Baseline demographics were comparable across groups. HoLEP patients had a significantly higher resected tissue weight (95.0 g vs. 26.0 g, p = 0.008) and required greater cushion volume (8.0 ml vs. 7.0 ml, p = 0.035). Complete continence rates were 64.7% (TUR-P) and 80.0% (HoLEP, p = 0.401). Postoperative pad test results (12.0 ml vs. 11.0 ml), complication rates, and satisfaction levels showed no significant differences. Explantation occurred in ~10% of patients, with high patient-reported satisfaction and willingness to recommend the implant across both groups.</p><p><strong>Conclusion: </strong>ATOMS implantation is a feasible, safe, and effective treatment for SUI following both TUR-P and HoLEP. Importantly, neither the type of prior surgery nor the volume of resected prostate tissue negatively impacted outcomes. These findings support the broader application of ATOMS in patients with post-BPE SUI, including those with large prostate volumes.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"372-378"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adhering to Clinical Advice: The Level of Alignment of Care Processes With Global Bladder Guidelines in Veterans With Spinal Cord Injuries or Diseases. 坚持临床建议:脊髓损伤或疾病退伍军人的护理过程与全球膀胱指南的一致性水平
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-10-06 DOI: 10.1002/nau.70146
John Lavelle, John Hornberger

Background: Guidelines contain recommendations for monitoring and care of neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury/disorder. Evidence on the level of adherence to these recommendations is limited.

Objectives: To assess treads in proportion of patients with spinal cord injury/disorder receiving commonly recommended processes of care for NLUTD.

Methods: The cohort consisted of 49 326 veterans with supra-sacral spinal cord injury or disorder (SCI/D) within the Veterans Affairs (V.A.) healthcare system first seen from fiscal year 1999-2024. Measures included laboratories, imaging, bladder-care procedures, and whether the veteran was seen by a urologist and had cystometrography (CMG).

Results: The analysis reveals the use of recommended NLUTD monitoring processes, with 41% undergoing renal imaging, 48% having a urology encounter, and 31% receiving cystometrography. A longitudinal view shows a decline in these rates over time. However, CMG rates exhibited some increase in veterans entering the system between 2005 and 2014, indicating a slight improvement in adherence over time.

Conclusions: The study highlights gaps between current practices and recommended processes for NLUTD, which may compromise outcomes for veterans with supra-sacral SCI/D. Further research is necessary to explore the barriers to executing suggested processes and implications for outcomes of this vulnerable population.

背景:指南包含脊髓损伤/疾病患者神经源性下尿路功能障碍(NLUTD)的监测和护理建议。关于遵守这些建议程度的证据是有限的。目的:评估脊髓损伤/疾病患者接受NLUTD通常推荐的护理过程的比例。方法:该队列包括1999-2024财政年度在退伍军人事务(va)医疗保健系统中首次出现的49326名骶上脊髓损伤或障碍(SCI/D)退伍军人。测量包括实验室、成像、膀胱护理程序,以及退伍军人是否被泌尿科医生看到并进行了膀胱造影(CMG)。结果:分析显示使用推荐的NLUTD监测过程,41%接受肾脏成像,48%接受泌尿科就诊,31%接受膀胱造影。纵向观察显示,这些比率随着时间的推移而下降。然而,在2005年至2014年期间,进入该系统的退伍军人的CMG率有所增加,这表明随着时间的推移,依从性略有改善。结论:该研究强调了NLUTD的当前实践和推荐流程之间的差距,这可能会影响骶骨上脊髓损伤/D退伍军人的预后。有必要进行进一步的研究,以探讨执行所建议的程序的障碍以及对这一弱势群体的结果的影响。
{"title":"Adhering to Clinical Advice: The Level of Alignment of Care Processes With Global Bladder Guidelines in Veterans With Spinal Cord Injuries or Diseases.","authors":"John Lavelle, John Hornberger","doi":"10.1002/nau.70146","DOIUrl":"10.1002/nau.70146","url":null,"abstract":"<p><strong>Background: </strong>Guidelines contain recommendations for monitoring and care of neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury/disorder. Evidence on the level of adherence to these recommendations is limited.</p><p><strong>Objectives: </strong>To assess treads in proportion of patients with spinal cord injury/disorder receiving commonly recommended processes of care for NLUTD.</p><p><strong>Methods: </strong>The cohort consisted of 49 326 veterans with supra-sacral spinal cord injury or disorder (SCI/D) within the Veterans Affairs (V.A.) healthcare system first seen from fiscal year 1999-2024. Measures included laboratories, imaging, bladder-care procedures, and whether the veteran was seen by a urologist and had cystometrography (CMG).</p><p><strong>Results: </strong>The analysis reveals the use of recommended NLUTD monitoring processes, with 41% undergoing renal imaging, 48% having a urology encounter, and 31% receiving cystometrography. A longitudinal view shows a decline in these rates over time. However, CMG rates exhibited some increase in veterans entering the system between 2005 and 2014, indicating a slight improvement in adherence over time.</p><p><strong>Conclusions: </strong>The study highlights gaps between current practices and recommended processes for NLUTD, which may compromise outcomes for veterans with supra-sacral SCI/D. Further research is necessary to explore the barriers to executing suggested processes and implications for outcomes of this vulnerable population.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"353-358"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145239373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the Scalpel: Integrating Digital Health and Artificial Intelligence to Refine Stress Urinary Incontinence Treatment Pathways. 超越手术刀:整合数字健康和人工智能,完善压力性尿失禁治疗途径。
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-11-12 DOI: 10.1002/nau.70184
Arsalan Ikram Shah, Wenjuan Sun, Kunpeng Yang, Yong Wang
{"title":"Beyond the Scalpel: Integrating Digital Health and Artificial Intelligence to Refine Stress Urinary Incontinence Treatment Pathways.","authors":"Arsalan Ikram Shah, Wenjuan Sun, Kunpeng Yang, Yong Wang","doi":"10.1002/nau.70184","DOIUrl":"10.1002/nau.70184","url":null,"abstract":"","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"421-422"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145496339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does Supramaximum Force Exist? Who Can Prove It? 超极力存在吗?谁能证明?
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-05 DOI: 10.1002/nau.70194
Laira Ramos
{"title":"Does Supramaximum Force Exist? Who Can Prove It?","authors":"Laira Ramos","doi":"10.1002/nau.70194","DOIUrl":"10.1002/nau.70194","url":null,"abstract":"","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"425-426"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145678236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of Repeat Trial Without Catheter in Patients With Urinary Retention Who Failed the First Attempt at Trial Without Catheter: A 10-Year Retrospective Study. 一次无导管试验失败的尿潴留患者重复无导管试验的意义:一项10年回顾性研究
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-09 DOI: 10.1002/nau.70202
Masato Takanashi, Hiroki Ito, Kazuhide Makiyama, Kazuki Kobayashi
<p><strong>Introduction: </strong>Trial without catheter (TWOC) is used to determine whether patients with acute urinary retention can achieve a catheter-free status. In clinical practice, it is common to repeat TWOC in patients who fail to void without a catheter during the first TWOC attempt. We investigated the outcomes and significance of repeat TWOC in male and female patients and aimed to identify predictors of successful outcomes of repeat TWOC based on patient backgrounds.</p><p><strong>Material and methods: </strong>Patients with acute urinary retention who underwent TWOC at a single center between 2010 and 2019 were enrolled and retrospectively analyzed. In the TWOC, the urinary catheter was removed after the instillation of warm saline (200-300 mL), and residual urine was measured after the first void. The trial was defined as unsuccessful if the patient had difficulty in voiding because of abdominal discomfort or pain. The decision to repeat the TWOC in patients who failed the first trial was made by each physician. Patients were divided into the single-trial and repeat-trial groups, and clinical factors predicting successful outcomes for each TWOC were analyzed using a multivariate logistic regression model.</p><p><strong>Results: </strong>Overall, 681 consecutive patients (577 male and 104 female) were diagnosed with acute urinary retention and underwent TWOC. Among the 577 male patients, 441 (76.4%) underwent TWOC only once (single-trial group), and 136 (23.6%) underwent TWOC twice or more (repeat-trial group). Among the 104 female patients, 84 (80.8%) and 20 (19.2%) underwent single and repeat TWOC, respectively. The overall success rate of TWOC for the single-trial and repeat-trial groups was not significantly different in either sex: 61.9% (273/441, single trial) and 55.1% (75/136, repeat trial) in male patients (p = 0.159) and 58.3% (49/84, single trial) and 55.0% (11/20, repeat trial) in female patients (p = 0.786). In the repeat-trial group, no significant and independent predictor of successful TWOC was found. In the single-trial group, low Eastern Cooperative Oncology Group performance status (odds ratio: 1.79 [1.1-2.9], p = 0.019) was identified as an independent predictor of a successful trial and absence of dementia (odds ratio: 3.82 [0.71-20.46], p = 0.118) was a possible predictor in male patients, whereas a high serum albumin level (odds ratio: 0.55 [0.27-1.15], p = 0.113) was a possible predictor of a successful trial in female patients.</p><p><strong>Conclusions: </strong>This is the first study to show the importance of repeated TWOC in male and female patients. The equivalent success rate of TWOC in the single and repeat TWOC groups for male and female patients indicates that repeat TWOC is justified as well as single TWOC, suggesting the importance of attempting repeat TWOC in patients of both sexes. This study also showed that predicting successful TWOC based on patient characteristics is difficult in repeat TWO
简介:试验无导管(TWOC)用于确定急性尿潴留患者是否可以达到无导管状态。在临床实践中,在第一次TWOC尝试时没有导管排空失败的患者重复TWOC是很常见的。我们调查了男性和女性患者重复TWOC的结果和意义,旨在根据患者背景确定重复TWOC成功结果的预测因素。材料和方法:纳入2010年至2019年在单一中心接受TWOC治疗的急性尿潴留患者并进行回顾性分析。TWOC组在输注温生理盐水(200-300 mL)后拔除导尿管,第一次排空后测量残余尿量。如果患者因腹部不适或疼痛而排尿困难,则该试验被定义为不成功。在第一次试验失败的患者中重复TWOC的决定是由每位医生做出的。将患者分为单试验组和重复试验组,采用多因素logistic回归模型分析预测两组患者成功结局的临床因素。结果:总体而言,681例连续患者(577例男性,104例女性)被诊断为急性尿潴留并接受了TWOC治疗。577例男性患者中,441例(76.4%)仅接受了一次TWOC(单试验组),136例(23.6%)接受了两次或两次以上TWOC(重复试验组)。104例女性患者中,84例(80.8%)和20例(19.2%)分别接受了单次和重复TWOC。单试验组和重复试验组的TWOC总成功率男女差异无统计学意义:男性患者61.9%(273/441,单试验)和55.1%(75/136,重复试验)(p = 0.159),女性患者58.3%(49/84,单试验)和55.0%(11/20,重复试验)(p = 0.786)。在重复试验组中,没有发现TWOC成功的显著和独立的预测因子。在单试验组中,较低的东部肿瘤合作组表现状态(优势比:1.79 [1.1-2.9],p = 0.019)被确定为试验成功的独立预测因素,无痴呆(优势比:3.82 [0.71-20.46],p = 0.118)是男性患者的可能预测因素,而高血清白蛋白水平(优势比:0.55 [0.27-1.15],p = 0.113)是女性患者试验成功的可能预测因素。结论:这是第一个显示重复TWOC在男性和女性患者中的重要性的研究。男性和女性患者在单一和重复TWOC组中相同的成功率表明,重复TWOC与单一TWOC一样是合理的,这表明在两性患者中尝试重复TWOC的重要性。该研究还表明,基于患者特征预测成功的两次TWOC在重复TWOC中是困难的,但在第一次TWOC中是可能的。临床试验注册:我们的研究是一项观察性研究,不是临床试验,因此不需要注册。
{"title":"Significance of Repeat Trial Without Catheter in Patients With Urinary Retention Who Failed the First Attempt at Trial Without Catheter: A 10-Year Retrospective Study.","authors":"Masato Takanashi, Hiroki Ito, Kazuhide Makiyama, Kazuki Kobayashi","doi":"10.1002/nau.70202","DOIUrl":"10.1002/nau.70202","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Trial without catheter (TWOC) is used to determine whether patients with acute urinary retention can achieve a catheter-free status. In clinical practice, it is common to repeat TWOC in patients who fail to void without a catheter during the first TWOC attempt. We investigated the outcomes and significance of repeat TWOC in male and female patients and aimed to identify predictors of successful outcomes of repeat TWOC based on patient backgrounds.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Material and methods: &lt;/strong&gt;Patients with acute urinary retention who underwent TWOC at a single center between 2010 and 2019 were enrolled and retrospectively analyzed. In the TWOC, the urinary catheter was removed after the instillation of warm saline (200-300 mL), and residual urine was measured after the first void. The trial was defined as unsuccessful if the patient had difficulty in voiding because of abdominal discomfort or pain. The decision to repeat the TWOC in patients who failed the first trial was made by each physician. Patients were divided into the single-trial and repeat-trial groups, and clinical factors predicting successful outcomes for each TWOC were analyzed using a multivariate logistic regression model.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Overall, 681 consecutive patients (577 male and 104 female) were diagnosed with acute urinary retention and underwent TWOC. Among the 577 male patients, 441 (76.4%) underwent TWOC only once (single-trial group), and 136 (23.6%) underwent TWOC twice or more (repeat-trial group). Among the 104 female patients, 84 (80.8%) and 20 (19.2%) underwent single and repeat TWOC, respectively. The overall success rate of TWOC for the single-trial and repeat-trial groups was not significantly different in either sex: 61.9% (273/441, single trial) and 55.1% (75/136, repeat trial) in male patients (p = 0.159) and 58.3% (49/84, single trial) and 55.0% (11/20, repeat trial) in female patients (p = 0.786). In the repeat-trial group, no significant and independent predictor of successful TWOC was found. In the single-trial group, low Eastern Cooperative Oncology Group performance status (odds ratio: 1.79 [1.1-2.9], p = 0.019) was identified as an independent predictor of a successful trial and absence of dementia (odds ratio: 3.82 [0.71-20.46], p = 0.118) was a possible predictor in male patients, whereas a high serum albumin level (odds ratio: 0.55 [0.27-1.15], p = 0.113) was a possible predictor of a successful trial in female patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This is the first study to show the importance of repeated TWOC in male and female patients. The equivalent success rate of TWOC in the single and repeat TWOC groups for male and female patients indicates that repeat TWOC is justified as well as single TWOC, suggesting the importance of attempting repeat TWOC in patients of both sexes. This study also showed that predicting successful TWOC based on patient characteristics is difficult in repeat TWO","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"390-398"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145708684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Mediating Role of Depression in the Association Between Food Insecurity and Lower Urinary Tract Symptoms in Middle-Aged and Older Men: A Population-Based Study. 抑郁在中老年男性食物不安全与下尿路症状之间的中介作用:一项基于人群的研究
IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-15 DOI: 10.1002/nau.70209
Meixiang Han, Cailiu Wei, Yong Fang, Yiqi Huang, Yanling Zhang, Zhongjie Qu, Fenjuan Chen

Objective: This study aimed to explore the association between food insecurity (FI) and lower urinary tract symptoms (LUTS) in middle-aged and older men, and to evaluate the mediating role of depression in this relationship.

Methods: Data were drawn from the National Health and Nutrition Examination Survey (NHANES) 2005-2008, including 2777 men aged 40 years and older. FI was assessed using the Household Food Security Survey Module, depression was measured by the PHQ-9 scale, and LUTS were identified via symptoms such as hesitancy, incomplete bladder emptying, incontinence, and nocturia. Weighted logistic regression and restricted cubic spline models were applied to assess associations. Mediation analysis was conducted using depression as a mediator.

Results: After full adjustment, FI was significantly associated with higher odds of incomplete bladder emptying (OR = 1.94, 95% CI: 1.11-3.36), urinary incontinence (OR = 2.11, 95% CI: 1.44-3.09), nocturia (OR = 1.59, 95% CI: 1.11-2.29), and clinical LUTS (OR = 2.49, 95% CI: 1.63-3.80). Moreover, higher PHQ-9 scores were consistently associated with increased odds of all types of LUTS, including urinary hesitancy, incomplete bladder emptying, urinary incontinence, nocturia, and clinical LUTS, in a dose-dependent manner. Mediation analysis indicated that depression partially mediated the association between FI and LUTS. Specifically, depression accounted for 12.22% of the effect of FI on urinary hesitancy, 8.90% on incomplete bladder emptying, 9.90% on urinary incontinence, 7.74% on nocturia, and 6.69% on clinical LUTS (all p < 0.05). These results demonstrate that depression plays a modest but statistically significant mediating role in the pathway linking FI to LUTS.

Conclusions: FI is significantly associated with multiple LUTS among middle-aged and older men, with depression partially mediating this relationship. Addressing both food access and mental health, particularly depression, may be critical for mitigating LUTS burden in this population.

Clinical trial registration number: Our study does not require a clinical trial registration. The survey data of our study are publicly available on the internet for data users and researchers throughout the world (https://www.cdc.gov/nchs/nhanes/?CDC_AAref_Val=https://www.cdc.gov/nchs/nhanes/index.htm).

目的:本研究旨在探讨中老年男性食物不安全(FI)与下尿路症状(LUTS)的关系,并评估抑郁在这一关系中的中介作用。方法:数据来自2005-2008年国家健康与营养调查(NHANES),包括2777名年龄在40岁及以上的男性。FI采用家庭食品安全调查模块进行评估,抑郁症采用PHQ-9量表进行测量,LUTS通过犹豫、膀胱排空不全、大小便失禁和夜尿等症状进行识别。加权逻辑回归和限制三次样条模型用于评估相关性。以抑郁为中介进行中介分析。结果:完全调整后,FI与膀胱排空不完全(OR = 1.94, 95% CI: 1.11-3.36)、尿失禁(OR = 2.11, 95% CI: 1.44-3.09)、夜尿症(OR = 1.59, 95% CI: 1.11-2.29)和临床LUTS (OR = 2.49, 95% CI: 1.63-3.80)的发生率显著相关。此外,较高的PHQ-9评分始终与所有类型LUTS的发生率增加相关,包括尿犹豫、膀胱排空不全、尿失禁、夜尿症和临床LUTS,并呈剂量依赖性。中介分析表明,抑郁在FI与LUTS之间起部分中介作用。其中,抑郁症在FI对尿犹豫的影响中占12.22%,在膀胱排空不全的影响中占8.90%,在尿失禁中占9.90%,在夜尿症中占7.74%,在临床LUTS中占6.69%(均为p)。结论:FI与中老年男性多发性LUTS显著相关,抑郁症在其中起部分作用。解决食物获取和心理健康问题,特别是抑郁症问题,可能对减轻这一人群的LUTS负担至关重要。临床试验注册号:我们的研究不需要临床试验注册。我们研究的调查数据在互联网上公开,供全世界的数据用户和研究人员使用(https://www.cdc.gov/nchs/nhanes/?CDC_AAref_Val=https://www.cdc.gov/nchs/nhanes/index.htm)。
{"title":"The Mediating Role of Depression in the Association Between Food Insecurity and Lower Urinary Tract Symptoms in Middle-Aged and Older Men: A Population-Based Study.","authors":"Meixiang Han, Cailiu Wei, Yong Fang, Yiqi Huang, Yanling Zhang, Zhongjie Qu, Fenjuan Chen","doi":"10.1002/nau.70209","DOIUrl":"10.1002/nau.70209","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to explore the association between food insecurity (FI) and lower urinary tract symptoms (LUTS) in middle-aged and older men, and to evaluate the mediating role of depression in this relationship.</p><p><strong>Methods: </strong>Data were drawn from the National Health and Nutrition Examination Survey (NHANES) 2005-2008, including 2777 men aged 40 years and older. FI was assessed using the Household Food Security Survey Module, depression was measured by the PHQ-9 scale, and LUTS were identified via symptoms such as hesitancy, incomplete bladder emptying, incontinence, and nocturia. Weighted logistic regression and restricted cubic spline models were applied to assess associations. Mediation analysis was conducted using depression as a mediator.</p><p><strong>Results: </strong>After full adjustment, FI was significantly associated with higher odds of incomplete bladder emptying (OR = 1.94, 95% CI: 1.11-3.36), urinary incontinence (OR = 2.11, 95% CI: 1.44-3.09), nocturia (OR = 1.59, 95% CI: 1.11-2.29), and clinical LUTS (OR = 2.49, 95% CI: 1.63-3.80). Moreover, higher PHQ-9 scores were consistently associated with increased odds of all types of LUTS, including urinary hesitancy, incomplete bladder emptying, urinary incontinence, nocturia, and clinical LUTS, in a dose-dependent manner. Mediation analysis indicated that depression partially mediated the association between FI and LUTS. Specifically, depression accounted for 12.22% of the effect of FI on urinary hesitancy, 8.90% on incomplete bladder emptying, 9.90% on urinary incontinence, 7.74% on nocturia, and 6.69% on clinical LUTS (all p < 0.05). These results demonstrate that depression plays a modest but statistically significant mediating role in the pathway linking FI to LUTS.</p><p><strong>Conclusions: </strong>FI is significantly associated with multiple LUTS among middle-aged and older men, with depression partially mediating this relationship. Addressing both food access and mental health, particularly depression, may be critical for mitigating LUTS burden in this population.</p><p><strong>Clinical trial registration number: </strong>Our study does not require a clinical trial registration. The survey data of our study are publicly available on the internet for data users and researchers throughout the world (https://www.cdc.gov/nchs/nhanes/?CDC_AAref_Val=https://www.cdc.gov/nchs/nhanes/index.htm).</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"399-408"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145756244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurourology and Urodynamics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1